Exploring a Treatment Option for Patients with Previously Treated Metastatic Small Cell Lung Cancer (SCLC)
Jazz Pharmaceuticals is proud to sponsor a theater presentation during the 2021 Oncology Nursing Society (ONS) Bridge. We invite you to join this expert-led discussion Exploring a Treatment Option for Patients with Previously Treated Metastatic Small Cell Lung Cancer (SCLC).
- This program will explore:
- An overview of unmet needs in SCLC
- Current treatment guidelines for SCLC
- Efficacy and safety findings from a study of an FDA-approved treatment for previously treated metastatic SCLC
- Considerations for dosing, administration, and patient counseling
Click here to register for the live presentation on Tuesday, September 14th from 3:00 pm to 3:45 pm EST